StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stagezero begins COVID-19 testing for travel to China $$$$$$

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Dec 02, 2020 7:15pm

189 Views

Post# 32023253

RE:RE:RE:Stagezero begins COVID-19 testing for travel to China $$$$$$

MSmitty2020 wrote:
no gap based in this ... we need some Aristotle news and positive PP news ... other than that very little traction will be made

Pierretraderman wrote: WoW! fantastic with this important news SZLS will soon be at $ 1.40 very easily. I think tomorrow morning we'll see a big GAP-UP $$$$$$$$$$$$$$$$$$$$$$$$$$$$$

I agree - just adding an intangible here and we are unaware of actual numbers being tested so we stay close to the .70 until after the pp and Aristotle update - we just need to hear that it will be rolled out by Q1 and we will pick up steam on that. If its delayed again with a promise say end of 2021 then we suffer...........